Health Digest on MSN1y
The Tremfya Commercial Explained: Drug Uses, Side Effects, And More
The Tremfya (trem-FYE-ah) ad starts with a woman in a dark room with ... are considered to have a major interaction with ...
Forbes3mon
Rebate Game Played By PBMs And Drug Makers Limits Biosimilar Competition
CVS Caremark—the largest PBM in the U.S.—removed Humira from most of its commercial lists of reimbursable drugs starting April 1. In its place, the PBM included the Humira-referenced ...
Forbes2y
Amgen Adopts A Two-Price Strategy For The U.S.’s First Marketed Humira-Referenced Biosimilar, Amjevita
Yet most physicians don’t appear to have a problem prescribing Humira-referenced biosimilars ... Different markets - commercial, Medicaid, Medicare - have wildly divergent net prices for ...
Hosted on MSN21d
AbbVie's SWOT analysis: biopharmaceutical giant navigates post-Humira landscape
Analysts note that the market's concern over Humira's impact is fading, with AbbVie's management effectively addressing the issue each quarter. The company's ability to execute its commercial ...
pharmaphorum1y
AbbVie’s new drugs keep post-Humira prospects on track
At one point Humira (adalimumab ... up nearly $4 billion on 2022. AbbVie’s head of commercial Jeff Stewart said on the results call that the two products have “substantial room for continued ...
pharmaphorum6y
Fourth Humira biosimilar set for EU approval
Its Commercial Medicines Unit will then begin its procurement process for adalimumab, considering Humira as well as its biosimilar rivals. New contracts are then expected to be in place by ...
Becker's Hospital Review29d
Big 3 PBM formularies favor private-label biosimilars
Humira (adalimumab), a popular immunosuppressive medication, and its 22 biosimilars are largely absent from the formularies of Cigna's Express Scripts, CVS Caremark and UnitedHealth Group's Optum Rx.